| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K09344309 |
| PharmacoGx | BRD-K09344309 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SLC15A5 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | GDF15 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.04 |
| mRNA | JAZF1 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.04 |
| mRNA | PPBP | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | LINC01125 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | TRMT61A | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | UBE2Z | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | GP9 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | SPHK1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.04 |
| mRNA | SLC16A10 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
